Sign In

Login

Password

Forgot Password ? Sign Up

Opioid excess theory (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Opioid excess theory" in English language version.

refsWebsite
Global rank English rank
12doi.org
2nd place
2nd place
11nih.gov
4th place
4th place
7semanticscholar.org
11th place
8th place
1nhs.uk
1,989th place
1,528th place
1apa.org
1,220th place
1,102nd place
1retractionwatch.com
low place
low place
1web.archive.org
1st place
1st place
1macalester.edu
low place
low place

apa.org

psycnet.apa.org

doi.org

  • Millward, C.; Ferriter, M.; Calver, S. J.; Connell-Jones, G. G. (2008). Ferriter, Michael (ed.). "Gluten- and casein-free diets for autistic spectrum disorder". The Cochrane Database of Systematic Reviews (2): CD003498. doi:10.1002/14651858.CD003498.pub3. PMC 4164915. PMID 18425890.
  • Panksepp, J. (1979). "A neurochemical theory of autism". Trends in Neurosciences. 2: 174–177. doi:10.1016/0166-2236(79)90071-7. S2CID 54373822.
  • Wakefield, A. J.; Murch, S. H.; Anthony, A.; Linnell, J.; Casson, D. M.; Malik, M.; Berelowitz, M.; Dhillon, A. P.; Thomson, M. A.; Harvey, P.; Valentine, A.; Davies, S. E.; Walker-Smith, J. A. (1998). "RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children". The Lancet. 351 (9103): 637–641. doi:10.1016/S0140-6736(97)11096-0. PMID 9500320. S2CID 439791. (Retracted, see doi:10.1016/S0140-6736(10)60175-4, PMID 20137807,  Retraction Watch)
  • Knivsberg, A. M.; Reichelt, K. L.; n⊘Dland, M.; h⊘Ien, T. (1995). "Autistic Syndromes and Diet: A follow-up study". Scandinavian Journal of Educational Research. 39 (3): 223–236. doi:10.1080/0031383950390304.
  • Lensing, P.; Schimke, H.; Klimesch, W.; Pap, V.; Szemes, G.; Klingler, D.; Panksepp, J. (1995). "Clinical case report: Opiate antagonist and event-related desynchronization in 2 autistic boys". Neuropsychobiology. 31 (1): 16–23. doi:10.1159/000119167. PMID 7708177.
  • Sahley, T. L.; Panksepp, J. (1987). "Brain opioids and autism: An updated analysis of possible linkages". Journal of Autism and Developmental Disorders. 17 (2): 201–216. doi:10.1007/BF01495056. PMID 3038836. S2CID 46566945.
  • Bouvard, M. P.; Leboyer, M.; Launay, J. M.; Recasens, C.; Plumet, M. H.; Waller-Perotte, D.; Tabuteau, F.; Bondoux, D.; Dugas, M.; Lensing, P.; Panksepp, J. (1995). "Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: A double-blind, placebo-controlled study". Psychiatry Research. 58 (3): 191–201. doi:10.1016/0165-1781(95)02601-R. PMID 8570775. S2CID 26253683.
  • Gillberg, C. (1995). "Endogenous opioids and opiate antagonists in autism: Brief review of empirical findings and implications for clinicians". Developmental Medicine & Child Neurology. 37 (3): 239–245. doi:10.1111/j.1469-8749.1995.tb11998.x. PMID 7890130. S2CID 28604551.
  • Hunter, L. C.; O'Hare, A.; Herron, W. J.; Fisher, L. A.; Jones, G. E. (2007). "Opioid peptides and dipeptidyl peptidase in autism". Developmental Medicine & Child Neurology. 45 (2): 121–8. doi:10.1111/j.1469-8749.2003.tb00915.x. PMID 12578238. S2CID 38949901.
  • Cass, H.; Gringras, P.; March, J.; McKendrick, I.; O'Hare, A. E.; Owen, L.; Pollin, C. (2008). "Absence of urinary opioid peptides in children with autism". Archives of Disease in Childhood. 93 (9): 745–750. doi:10.1136/adc.2006.114389. PMID 18337276.
  • Mulloy, Austin; Lang, Russell; O’Reilly, Mark; Sigafoos, Jeff; Lancioni, Giulio; Rispoli, Mandy (July 2010). "Gluten-free and casein-free diets in the treatment of autism spectrum disorders: A systematic review". Research in Autism Spectrum Disorders. 4 (3): 328–339. doi:10.1016/j.rasd.2009.10.008.
  • Roy, A; Roy, M; Deb, S; Unwin, G; Roy, A (2014). "Are opioid antagonists effective in attenuating the core symptoms of autism spectrum conditions in children: A systematic review". Journal of Intellectual Disability Research. 59 (4): 293–306. doi:10.1111/jir.12122. PMID 24589346. S2CID 11896817.

macalester.edu

nhs.uk

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Millward, C.; Ferriter, M.; Calver, S. J.; Connell-Jones, G. G. (2008). Ferriter, Michael (ed.). "Gluten- and casein-free diets for autistic spectrum disorder". The Cochrane Database of Systematic Reviews (2): CD003498. doi:10.1002/14651858.CD003498.pub3. PMC 4164915. PMID 18425890.
  • Reichelt, K. L.; Hole, K.; Hamberger, A.; et al. (1981). "Biologically active peptide-containing fractions in schizophrenia and childhood autism". Advances in Biochemical Psychopharmacology. 28: 627–643. PMID 7010949.
  • Wakefield, A. J.; Murch, S. H.; Anthony, A.; Linnell, J.; Casson, D. M.; Malik, M.; Berelowitz, M.; Dhillon, A. P.; Thomson, M. A.; Harvey, P.; Valentine, A.; Davies, S. E.; Walker-Smith, J. A. (1998). "RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children". The Lancet. 351 (9103): 637–641. doi:10.1016/S0140-6736(97)11096-0. PMID 9500320. S2CID 439791. (Retracted, see doi:10.1016/S0140-6736(10)60175-4, PMID 20137807,  Retraction Watch)
  • Lensing, P.; Schimke, H.; Klimesch, W.; Pap, V.; Szemes, G.; Klingler, D.; Panksepp, J. (1995). "Clinical case report: Opiate antagonist and event-related desynchronization in 2 autistic boys". Neuropsychobiology. 31 (1): 16–23. doi:10.1159/000119167. PMID 7708177.
  • Sahley, T. L.; Panksepp, J. (1987). "Brain opioids and autism: An updated analysis of possible linkages". Journal of Autism and Developmental Disorders. 17 (2): 201–216. doi:10.1007/BF01495056. PMID 3038836. S2CID 46566945.
  • Bouvard, M. P.; Leboyer, M.; Launay, J. M.; Recasens, C.; Plumet, M. H.; Waller-Perotte, D.; Tabuteau, F.; Bondoux, D.; Dugas, M.; Lensing, P.; Panksepp, J. (1995). "Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: A double-blind, placebo-controlled study". Psychiatry Research. 58 (3): 191–201. doi:10.1016/0165-1781(95)02601-R. PMID 8570775. S2CID 26253683.
  • Gillberg, C. (1995). "Endogenous opioids and opiate antagonists in autism: Brief review of empirical findings and implications for clinicians". Developmental Medicine & Child Neurology. 37 (3): 239–245. doi:10.1111/j.1469-8749.1995.tb11998.x. PMID 7890130. S2CID 28604551.
  • Hunter, L. C.; O'Hare, A.; Herron, W. J.; Fisher, L. A.; Jones, G. E. (2007). "Opioid peptides and dipeptidyl peptidase in autism". Developmental Medicine & Child Neurology. 45 (2): 121–8. doi:10.1111/j.1469-8749.2003.tb00915.x. PMID 12578238. S2CID 38949901.
  • Cass, H.; Gringras, P.; March, J.; McKendrick, I.; O'Hare, A. E.; Owen, L.; Pollin, C. (2008). "Absence of urinary opioid peptides in children with autism". Archives of Disease in Childhood. 93 (9): 745–750. doi:10.1136/adc.2006.114389. PMID 18337276.
  • Roy, A; Roy, M; Deb, S; Unwin, G; Roy, A (2014). "Are opioid antagonists effective in attenuating the core symptoms of autism spectrum conditions in children: A systematic review". Journal of Intellectual Disability Research. 59 (4): 293–306. doi:10.1111/jir.12122. PMID 24589346. S2CID 11896817.

ncbi.nlm.nih.gov

  • Millward, C.; Ferriter, M.; Calver, S. J.; Connell-Jones, G. G. (2008). Ferriter, Michael (ed.). "Gluten- and casein-free diets for autistic spectrum disorder". The Cochrane Database of Systematic Reviews (2): CD003498. doi:10.1002/14651858.CD003498.pub3. PMC 4164915. PMID 18425890.

retractionwatch.com

semanticscholar.org

api.semanticscholar.org

web.archive.org